PL3423440T3 - Pochodna 5-metylo-6-fenylo-4,5-dihydro-2h-pirydazyn-3-onu do leczenia nowotworów mózgu - Google Patents
Pochodna 5-metylo-6-fenylo-4,5-dihydro-2h-pirydazyn-3-onu do leczenia nowotworów mózguInfo
- Publication number
- PL3423440T3 PL3423440T3 PL17711366T PL17711366T PL3423440T3 PL 3423440 T3 PL3423440 T3 PL 3423440T3 PL 17711366 T PL17711366 T PL 17711366T PL 17711366 T PL17711366 T PL 17711366T PL 3423440 T3 PL3423440 T3 PL 3423440T3
- Authority
- PL
- Poland
- Prior art keywords
- pyridazin
- dihydro
- phenyl
- derivative
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016042535 | 2016-03-04 | ||
| EP17711366.9A EP3423440B9 (en) | 2016-03-04 | 2017-03-02 | 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative for the treatment of brain tumors |
| PCT/JP2017/008246 WO2017150654A1 (en) | 2016-03-04 | 2017-03-02 | 5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3423440T3 true PL3423440T3 (pl) | 2021-07-26 |
Family
ID=58347859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17711366T PL3423440T3 (pl) | 2016-03-04 | 2017-03-02 | Pochodna 5-metylo-6-fenylo-4,5-dihydro-2h-pirydazyn-3-onu do leczenia nowotworów mózgu |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US10611731B2 (pl) |
| EP (1) | EP3423440B9 (pl) |
| JP (1) | JP6596595B2 (pl) |
| KR (1) | KR102350772B1 (pl) |
| CN (1) | CN108779076B (pl) |
| AU (2) | AU2017226674B2 (pl) |
| CA (1) | CA3015331A1 (pl) |
| CY (1) | CY1123927T1 (pl) |
| DK (1) | DK3423440T3 (pl) |
| EA (1) | EA036423B1 (pl) |
| ES (1) | ES2862177T3 (pl) |
| HR (1) | HRP20210395T1 (pl) |
| HU (1) | HUE053358T2 (pl) |
| IL (1) | IL261225B (pl) |
| LT (1) | LT3423440T (pl) |
| MX (1) | MX2018010535A (pl) |
| MY (1) | MY196801A (pl) |
| NZ (1) | NZ745688A (pl) |
| PH (1) | PH12018501873A1 (pl) |
| PL (1) | PL3423440T3 (pl) |
| PT (1) | PT3423440T (pl) |
| RS (1) | RS61593B1 (pl) |
| SA (1) | SA518392275B1 (pl) |
| SG (1) | SG11201807146SA (pl) |
| SI (1) | SI3423440T1 (pl) |
| TW (1) | TWI731041B (pl) |
| WO (1) | WO2017150654A1 (pl) |
| ZA (1) | ZA201805791B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7104588B2 (ja) * | 2017-09-01 | 2022-07-21 | 大塚製薬株式会社 | ５－メチル－６－フェニル－４，５－ジヒドロ－２ｈ－ピリダジン－３－オン誘導体を含有する悪性腫瘍治療剤 |
| WO2020157194A1 (en) * | 2019-02-01 | 2020-08-06 | Bayer Aktiengesellschaft | 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63145272A (ja) * | 1986-12-09 | 1988-06-17 | Morishita Seiyaku Kk | ４，５−ジヒドロ−６−（４−置換フエニル）−３（２ｈ）−ピリダジノン誘導体 |
| US5100892A (en) * | 1990-11-13 | 1992-03-31 | Glaxo Inc. | Dihydropyridine vasodilator agents |
| US5563143A (en) * | 1994-09-21 | 1996-10-08 | Pfizer Inc. | Catechol diether compounds as inhibitors of TNF release |
| CN1136197C (zh) * | 1996-05-30 | 2004-01-28 | 霍夫曼-拉罗奇有限公司 | 新的哒嗪酮衍生物 |
| CA2588949A1 (en) * | 2004-11-30 | 2006-06-08 | Artesian Therapeutics, Inc. | Compounds with mixed pde-inhibitory and .beta.-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| EP2168959A1 (en) | 2007-06-19 | 2010-03-31 | Kyorin Pharmaceutical Co., Ltd. | Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| CN101537006B (zh) | 2008-03-18 | 2012-06-06 | 中国科学院上海药物研究所 | 哒嗪酮类化合物在制备抗肿瘤药物中的用途 |
| EP2970145B1 (en) * | 2013-03-11 | 2020-05-06 | The Broad Institute, Inc. | Compounds and compositions for the treatment of cancer |
-
2017
- 2017-03-02 CN CN201780013870.4A patent/CN108779076B/zh active Active
- 2017-03-02 HU HUE17711366A patent/HUE053358T2/hu unknown
- 2017-03-02 EP EP17711366.9A patent/EP3423440B9/en active Active
- 2017-03-02 DK DK17711366.9T patent/DK3423440T3/da active
- 2017-03-02 AU AU2017226674A patent/AU2017226674B2/en active Active
- 2017-03-02 MY MYPI2018703021A patent/MY196801A/en unknown
- 2017-03-02 KR KR1020187028010A patent/KR102350772B1/ko active IP Right Grant
- 2017-03-02 RS RS20210193A patent/RS61593B1/sr unknown
- 2017-03-02 MX MX2018010535A patent/MX2018010535A/es unknown
- 2017-03-02 SG SG11201807146SA patent/SG11201807146SA/en unknown
- 2017-03-02 SI SI201730668T patent/SI3423440T1/sl unknown
- 2017-03-02 PL PL17711366T patent/PL3423440T3/pl unknown
- 2017-03-02 WO PCT/JP2017/008246 patent/WO2017150654A1/en active Application Filing
- 2017-03-02 ES ES17711366T patent/ES2862177T3/es active Active
- 2017-03-02 CA CA3015331A patent/CA3015331A1/en active Pending
- 2017-03-02 TW TW106106813A patent/TWI731041B/zh active
- 2017-03-02 JP JP2018544577A patent/JP6596595B2/ja active Active
- 2017-03-02 NZ NZ745688A patent/NZ745688A/en unknown
- 2017-03-02 PT PT177113669T patent/PT3423440T/pt unknown
- 2017-03-02 US US16/081,260 patent/US10611731B2/en active Active
- 2017-03-02 EA EA201891987A patent/EA036423B1/ru not_active IP Right Cessation
- 2017-03-02 LT LTEP17711366.9T patent/LT3423440T/lt unknown
-
2018
- 2018-08-19 IL IL261225A patent/IL261225B/en unknown
- 2018-08-26 SA SA518392275A patent/SA518392275B1/ar unknown
- 2018-08-29 ZA ZA2018/05791A patent/ZA201805791B/en unknown
- 2018-09-03 PH PH12018501873A patent/PH12018501873A1/en unknown
-
2020
- 2020-02-12 US US16/788,894 patent/US20200181092A1/en not_active Abandoned
-
2021
- 2021-02-22 AU AU2021201135A patent/AU2021201135B2/en active Active
- 2021-02-23 US US17/182,549 patent/US20210171472A1/en active Pending
- 2021-02-24 CY CY20211100155T patent/CY1123927T1/el unknown
- 2021-03-08 HR HRP20210395TT patent/HRP20210395T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1244280B (zh) | 用於治療感染性疾病的吡嗪化合物 | |
| IL264049A (en) | Compounds, preparations and methods for treating the disease | |
| ZA201905902B (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| HK1247202A1 (zh) | 用於治療癌症的化合物 | |
| IL260443B (en) | Combinations of anti-egfr for cancer treatment | |
| SG10201913409VA (en) | Methods for solid tumor treatment | |
| IL264156A (en) | Compounds, preparations and methods for treating the disease | |
| IL260444B (en) | Anti-her2 combinations for cancer treatment | |
| IL260442B (en) | Combinations of anti-cd20 for cancer treatment | |
| IL249229A0 (en) | Compounds for the treatment of brain cancer | |
| EP3606962A4 (en) | TREATMENT METHODS FOR HIGH CD73 TUMORS | |
| IL259996A (en) | Combinations for cancer treatment | |
| ZA201707737B (en) | Composition for treating brain lesions | |
| ZA201901578B (en) | Combinations including abx196 for the treatment of cancer | |
| EP3548007A4 (en) | CANCER TREATMENT METHODS | |
| SI3423440T1 (sl) | 5-metil-6-fenil-4,5-dihidro-2H-piridazin-3-ON derivat za zdravljenje možganskih tumorjev | |
| EP3541474A4 (en) | TREATMENT OF BONE-RELATED DISORDERS | |
| EP3432884A4 (en) | COMBINATIONS FOR THE TREATMENT OF PAIN | |
| PT3580211T (pt) | 2-heteroaril-3-oxo-2,3-di-hidropiridazina-4-carboxamidas para o tratamento de cancro | |
| HRP20181123T1 (hr) | Spojevi 3,4-diamino-6-kloropirazin-2-karboksamida za liječenje bolesti posredovanih s enac | |
| GB201701933D0 (en) | New methods for the treatment of hyperglycaemia | |
| EP3331535A4 (en) | METHOD FOR TREATING TUMORS | |
| AU2015903130A0 (en) | Methods for treating tumours |